Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2014 Dec;66 Suppl 3(Suppl 3):S1-51.
doi: 10.1016/j.ihj.2014.12.001. Epub 2014 Dec 24.

Consensus statement on management of dyslipidemia in Indian subjects

K Sarat Chandra  1 , Manish Bansal  2 , Tiny Nair  3 , S S Iyengar  4 , Rajeev Gupta  5 , Subhash C Manchanda  6 , P P Mohanan  7 , V Dayasagar Rao  8 , C N Manjunath  9 , J P S Sawhney  10 , Nakul Sinha  11 , A K Pancholia  12 , Sundeep Mishra  13 , Ravi R Kasliwal  14 , Saumitra Kumar  15 , Unni Krishnan  16 , Sanjay Kalra  17 , Anoop Misra  18 , Usha Shrivastava  19 , Seema Gulati  20
Affiliations
Review

Consensus statement on management of dyslipidemia in Indian subjects

K Sarat Chandra et al. Indian Heart J. 2014 Dec.
No abstract available

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
World Health Organization cardiovascular risk prediction charts applicable for Indians (South-East Asia Region D). These charts predict 10-year risk of a fatal or non-fatal cardiovascular event.
Fig. 2
Fig. 2
Suggested cardiovascular risk assessment approach in Indians with dyslipidemia. * The major risk factors include-i) Cigarette smoking (any cigarette smoking during the last one month), ii) Hypertension (blood pressure ≥140/90 mmHg or on antihypertensive medication), iii) Low HDL-C cholesterol (<40 mg/dl), iv) Family history of premature CAD (CAD in male first-degree relative <55 years or in female first-degree relative <65 years), v) Age ≥45 years in men and ≥55 years in women). If the HDL-C cholesterol level is > 60 mg/dl, it is considered a negative risk factor CAD-coronary artery disease; CRP- c-reactive protein, HDL-C- high-density lipoprotein cholesterol; IFG-impaired fasting glucose; IGT-impaired glucose tolerance; ISH- International Society of Hypertension; JBS- Joint British Societies; WHO- World Health Organization.
Fig. 3
Fig. 3
Overall approach to lipid-lowering therapy for prevention of cardiovascular disease. (HDL-C- high-density lipoprotein cholesterol, LDL-C- low-density lipoprotein cholesterol). * Please note, non-HDL-C is an acceptable primary target of lipid lowering therapy if LDL-C values are not available or not reliable.
See this image and copyright information in PMC

References

    1. Gupta R. Burden of coronary heart disease in India. Indian Heart J. 2005;57:632–638. - PubMed
    1. Law M.R., Wald N.J., Thompson S.G. By how much and how quickly does reduction in serum cholesterol concentration lower risk of ischaemic heart disease? BMJ. 1994;308:367–372. - PMC - PubMed
    1. Yusuf S., Hawken S., Ounpuu S. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the interheart study): case-control study. Lancet. 2004;364:937–952. - PubMed
    1. Yusuf S., Islam S., Chow C.K. Use of secondary prevention drugs for cardiovascular disease in the community in high-income, middle-income, and low-income countries (the pure study): a prospective epidemiological survey. Lancet. 2011;378:1231–1243. - PubMed
    1. Rose G. Strategy of prevention: lessons from cardiovascular disease. Br Med J (Clin Res Ed. 1981;282:1847–1851. - PMC - PubMed

LinkOut - more resources